|
Neurofibromatosis
Signs and Symptoms: Neurofibromatosis (NF1) describes a variety of related syndromes characterized by neuroectodermal tumors arising within multiple organs. The term Von Recklinghausen's Neurofibro-matosis recognizes Friedrich Daniel Von Reckling-hausen, who first reported the constellation of findings in 1882. The diagnostic criteria for neurofibromatosis requires at least two of the these seven systemic signs:
These tissue changes may produce optic neuropathy or compromise the visual pathway. Pathophysiology: This inherited disorder is a disease of the neural crest, a transient embryonic structure composed of cells which migrate to various body parts to form neuronal, neural-supportive, pigmentary, endocrine or other tissues. Researchers are studying the precise disease mechanisms. Significant arrays of tissues which develop from neural crest derivatives make it impossible to tie the origin of Von Recklinghausen's neurofibromatosis to a single chemical, immunologic or cellular marker. Management: The individual course of neurofibromatosis is unpredictable, and management is difficult. There are no specific treatments, although some elements of the disease process are treatable. Children with this syndrome are susceptible to neurological complications and should undergo neuroimaging of the brain and orbit. T-2 weighted magnetic resonance imaging (MRI) can detect both intraorbital and intracranial optic nerve gliomas. Visual evoked potential (VEP) is useful for evaluating optic nerve function. Pattern visual evoked response (VER) is useful for assessing chiasmal involvement. Clinical Pearl:
Other reports in this section |
Eyelids
& Eyelashes | Conjunctiva
& Sclera | Cornea
Uvea | Vitreous & Retina
| Optic Nerve & Brain |
Oculosystemic Disease
Handbook Main Page